BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1028 related articles for article (PubMed ID: 9010910)

  • 1. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of menarche and first birth in relation to risk of breast cancer in A-bomb survivors.
    McDougall JA; Sakata R; Sugiyama H; Grant E; Davis S; Nishi N; Soda M; Shimizu Y; Tatsukawa Y; Kasagi F; Suyama A; Ross P; Kopecky KJ; Li CI
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1746-54. PubMed ID: 20570914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure.
    Nakashima M; Kondo H; Miura S; Soda M; Hayashi T; Matsuo T; Yamashita S; Sekine I
    Cancer Sci; 2008 Jan; 99(1):87-92. PubMed ID: 17979995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
    Howe GR; McLaughlin J
    Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
    Richardson DB
    Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
    Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
    Lagarde F
    Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.